共 4 条
[1]
Heart failure and neuroendocrine activation:d i-agnostic,prognostic and therapeutic perspectives. K jaer A,Hesse B. C lin Physiol . 2001
[2]
l Utility of B-type natri-uretic peptide as a rap id,point of care test for screen ing patients un-dergoing echocard iongraphy to determ ine left ventricu lar dys function. Maisel AS,Koon J,Krishnaswamy P,et a. American Heart Journal . 2001
[3]
Card iovascu lar morb id ityand mortality in the lorsartan intervention for endpoint reduction inhypertention study(LIFE):a random ized trial against atenolol. Dahlof B,D evereux RB,K jeldsen SE,et al. The Lancet . 2002
[4]
l Utility of B-type na-triuretic peptide in the d iagnosis of congestive heart failure in an ur-gent care setting. Dao Q,Krishnaswamy P,Kazanegra R,et a. Journal of the American College of Cardiology . 2001